Clinical trial
Efficacy and Safety of Clopidogrel for Primary Prevention in Patients With Subclinical Coronary Atherosclerosis Identified on Imaging
NCT05845489 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Clopidogrel for Primary Prevention in Patients With Subclinical Coronary Atherosclerosis Identified on Imaging
- Lead sponsor
- Seoul National University Hospital
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- March 22, 2023
- Completion date
- December 31, 2031
- Enrollment
- 11,086 (estimated)
- Sites
- 61
Conditions
As the registry lists them; a condition with its own page is linked.